Clinical Trials Directory

Trials / Completed

CompletedNCT00570440

Continuous Use of COCs

Continuous Versus Cyclic Use of Combined Oral Contraceptive Pills

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
362 (estimated)
Sponsor
FHI 360 · Academic / Other
Sex
Female
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

The primary objective is to determine if continuous COC use leads to higher continuation rates over 12 months of follow up than use of the standard 28-day COC regimen.

Detailed description

Family Health International has recently initiated a USAID funded study to investigate the pregnancy rates, continuation rates, and acceptability of COCs in women taking COCs by the 21/7 cyclic regimen compared with the continuous use of COCs with bleeding-signaled hormone-free intervals. The primary objective is to determine whether continuous COC use leads to higher 12-month continuation rates than use of the standard 28-day COC regimen. Secondary objectives are to 1) compare pregnancy probabilities through 6 and 12 months between the continuous use group and the 28-day group 2) compare COC continuation rates through 6 months between the continuous use group and the 28-day group 3) compare acceptability of the two COC regimens 4) to compare bleeding and other side effects between the continuous use group and the 28-day group 5) to compare hemoglobin/hematocrit between the continuous use group and the 28-day group

Conditions

Interventions

TypeNameDescription
DRUGOral contraceptives--ethinyl estradiol, levonorgestrel3 visits - screening/enrollment, 6-months and 12 months

Timeline

Start date
2007-08-01
Primary completion
2010-10-01
Completion
2010-10-01
First posted
2007-12-11
Last updated
2011-10-31

Locations

2 sites across 2 countries: Dominican Republic, Nicaragua

Source: ClinicalTrials.gov record NCT00570440. Inclusion in this directory is not an endorsement.